Getting medical cannabis in Israel is a structured, doctor-gated process run through the Ministry of Health and, since 2024, increasingly through the public health funds (HMOs). This is a plain-English guide to how it works. It is general information, not medical or legal advice — always confirm current details with your physician, your HMO and the Ministry of Health.
Who is eligible
Cannabis in Israel is approved only for specific recognised indications, not as a general wellness option. The most common qualifying conditions include chronic and neuropathic pain, PTSD, the side effects of cancer treatment (such as nausea, appetite loss and weight loss), and a set of other defined conditions including Tourette syndrome with functional impairment and dementia accompanied by behavioural disorders. In practice, chronic non-cancer pain accounts for the largest share of approvals, followed by PTSD.
A key principle: cannabis is generally treated as a later-line option, considered when standard treatments have been tried and have not worked well enough. Eligibility is decided on the medical merits of your case, not on demand.
The process, step by step
1. See the right specialist. A family doctor generally cannot initiate a cannabis request. The recommendation must come from a specialist physician in the relevant field — for example, a pain specialist, oncologist or psychiatrist — who is treating your condition and is authorised to recommend cannabis.
2. Get a medical recommendation. If the specialist judges that cannabis may help, they prepare a detailed recommendation documenting your diagnosis, prior treatments and the proposed cannabis therapy.
3. Approval and the licence or prescription. The recommendation goes to the Medical Cannabis Unit at the Ministry of Health (or, for many indications now, is handled within your HMO). If approved, you receive authorisation specifying your monthly dosage and the treatment period.
4. Fill it at an authorised pharmacy. With a valid licence or prescription you obtain product from a pharmacy licensed to dispense cannabis, within the dosage on your authorisation.
What the 2024 HMO reform changed
The biggest recent change is administrative. A 2024 reform moved much of the program into the health funds. Under it, patients with chronic pain or PTSD continue to receive Ministry licences, while many other recognised indications now receive prescriptions issued through the HMOs instead. The intent was to fold cannabis into mainstream care, but the practical effect for some patients has been stricter gatekeeping and more paperwork — one reason the national patient count declined for the first time after the reform. If you are renewing rather than starting, expect more involvement from your HMO than in previous years.
Products and formats
Israeli medical cannabis comes in several forms: dried flower (for inhalation), oils and extracts taken orally, capsules, and metered-dose inhalers. Dried flower has historically dominated, making up the large majority of usage. Note an important caveat for the years ahead: a Health Ministry committee has proposed phasing out smokable cannabis in favour of oils, extracts and inhalers, though that proposal has been frozen rather than enacted. If it ever advances, the mix of available formats could shift substantially.
Products are specified by their THC and CBD content and are sold under standardised categories, so a prescription typically corresponds to a defined product profile rather than a brand.
What it costs
Medical cannabis is not included in the national health basket, which means patients largely pay out of pocket. There are typically deductible-style charges from the HMO for the medical examination, the permit and the prescription, and then the product cost at the pharmacy. Because pharmacies set their own prices and discounts, costs vary — legal pharmacy flower commonly runs in the range of roughly ₪100–350 per 10 grams depending on product and outlet. Monthly cost depends on your prescribed dosage. Some patients — notably certain disabled IDF veterans — have part or all of their treatment funded.
Practical tips
Start with the specialist who already treats your condition, since they are best placed to make the case. Keep documentation of prior treatments, as recognised indications generally expect that conventional options have been tried first. Build in time: approvals and renewals are not instant, and the HMO-routed process can involve scheduling a physician meeting, especially for renewals beyond six months. And confirm pricing at more than one authorised pharmacy, since prices are not fixed.
This is general guidance only and may not reflect your individual circumstances or the latest rules. Verify everything with your physician, your HMO and the Israeli Ministry of Health.
Related: Regulation · Market overview · Research legacy
Compiled and reviewed by Tamar Levin, Editor. Sources are linked inline. This page is reviewed and refreshed periodically; it is informational and is not medical or legal advice.